Legal & General Group Plc increased its holdings in LHC Group (NASDAQ:LHCG) by 14.9% during the second quarter, according to its most recent disclosure with the SEC. The institutional investor owned 28,825 shares of the health services provider’s stock after buying an additional 3,738 shares during the period. Legal & General Group Plc owned 0.16% of LHC Group worth $1,956,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. First Mercantile Trust Co. bought a new position in shares of LHC Group during the second quarter valued at about $147,000. Invictus RG bought a new stake in shares of LHC Group in the first quarter worth about $125,000. US Bancorp DE grew its stake in shares of LHC Group by 25.1% in the first quarter. US Bancorp DE now owns 2,683 shares of the health services provider’s stock worth $145,000 after purchasing an additional 539 shares during the last quarter. State of Alaska Department of Revenue grew its stake in shares of LHC Group by 79.1% in the second quarter. State of Alaska Department of Revenue now owns 2,955 shares of the health services provider’s stock worth $200,000 after purchasing an additional 1,305 shares during the last quarter. Finally, Mason Street Advisors LLC grew its stake in shares of LHC Group by 7.0% in the first quarter. Mason Street Advisors LLC now owns 3,485 shares of the health services provider’s stock worth $188,000 after purchasing an additional 228 shares during the last quarter. Institutional investors and hedge funds own 85.93% of the company’s stock.
Several research firms have weighed in on LHCG. Royal Bank Of Canada reiterated a “buy” rating and set a $69.00 target price on shares of LHC Group in a report on Tuesday, July 18th. Benchmark Co. boosted their price objective on shares of LHC Group from $63.00 to $72.00 and gave the stock a “buy” rating in a report on Thursday, June 8th. Jefferies Group LLC restated a “buy” rating and issued a $68.00 price objective on shares of LHC Group in a report on Friday, August 4th. BidaskClub lowered shares of LHC Group from a “strong-buy” rating to a “buy” rating in a report on Wednesday, July 12th. Finally, Zacks Investment Research upgraded shares of LHC Group from a “hold” rating to a “buy” rating and set a $67.00 target price for the company in a research note on Saturday, August 5th. One analyst has rated the stock with a hold rating and ten have given a buy rating to the company. The company has a consensus rating of “Buy” and an average price target of $66.60.
ILLEGAL ACTIVITY NOTICE: This report was posted by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are accessing this report on another site, it was copied illegally and reposted in violation of international trademark and copyright law. The correct version of this report can be read at https://ledgergazette.com/2017/09/24/legal-general-group-plc-has-1-96-million-stake-in-lhc-group-lhcg.html.
LHC Group (LHCG) opened at 65.47 on Friday. LHC Group has a 12-month low of $32.04 and a 12-month high of $69.35. The stock has a market cap of $1.20 billion, a PE ratio of 28.97 and a beta of 0.76. The firm has a 50 day moving average of $63.81 and a 200-day moving average of $60.05.
LHC Group (NASDAQ:LHCG) last released its quarterly earnings results on Wednesday, August 2nd. The health services provider reported $0.63 EPS for the quarter, beating the consensus estimate of $0.54 by $0.09. LHC Group had a net margin of 4.13% and a return on equity of 9.62%. The firm had revenue of $260.20 million during the quarter, compared to the consensus estimate of $254.10 million. During the same quarter in the prior year, the firm earned $0.52 EPS. LHC Group’s revenue for the quarter was up 15.1% on a year-over-year basis. On average, analysts expect that LHC Group will post $2.39 earnings per share for the current year.
In related news, COO Donald Dwayne Stelly sold 2,650 shares of the stock in a transaction dated Friday, September 8th. The shares were sold at an average price of $65.34, for a total value of $173,151.00. Following the sale, the chief operating officer now directly owns 109,235 shares of the company’s stock, valued at approximately $7,137,414.90. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Company insiders own 14.80% of the company’s stock.
About LHC Group
LHC Group, Inc is a holding company. The Company provides post-acute healthcare services to patients through its home nursing agencies, hospice agencies, community-based services agencies and long-term acute care hospitals (LTACHs). The Company operates through four segments: home health services, hospice services, community-based services and facility-based services.
Want to see what other hedge funds are holding LHCG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for LHC Group (NASDAQ:LHCG).
Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.